Pancreatic Stone Protein: Review of a New Biomarker in Sepsis

Research output: Contribution to journalReview articlepeer-review

2 Citations (Scopus)

Abstract

Sepsis is a life-threatening syndrome characterized by a dysregulated host response to an infection that may evolve rapidly into septic shock and multiple organ failure. Management of sepsis relies on the early recognition and diagnosis of infection and the providing of adequate and prompt antibiotic therapy and organ support. A novel protein biomarker, the pancreatic stone protein (PSP), has recently been studied as a biomarker of sepsis and the available evidence suggests that it has a higher diagnostic performance for the identification of infection than the most used available biomarkers and adds prognostic value. This review summarizes the clinical evidence available for PSP in the diagnosis and prognosis of sepsis.

Original languageEnglish
Article number1085
JournalJournal of Clinical Medicine
Volume11
Issue number4
DOIs
Publication statusPublished - 1 Feb 2022

Keywords

  • Biomarker
  • Infection
  • Pancreatic stone protein
  • Sepsis

Fingerprint

Dive into the research topics of 'Pancreatic Stone Protein: Review of a New Biomarker in Sepsis'. Together they form a unique fingerprint.

Cite this